Moreover, in response to upregulation of IFN-γ and IL-10, cells from tumour microenvironment like antigen presenting cells (APCs), tumour associated myeloid derived suppressor cells (MDSC), and M2 macrophages are able to produce indolamine 2,3-dioxygenase (IDO). The gene discussed is IDO1; the disease is neoplasm.